Autocrine Communication < Autoimmune Diseases < Autoimmunity

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Autoimmune Diseases

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
000075 (2020)	Anca D. Askanase [États-Unis] ; Leila Khalili [États-Unis] ; Jill P. Buyon [États-Unis]	Thoughts on COVID-19 and autoimmune diseases
001076 (2018)	F. Proft [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Grunke [Allemagne] ; E. Schrezenmeier [Allemagne] ; F. Halleck [Allemagne] ; J. Henes [Allemagne] ; L. Unger [Allemagne] ; E. Schmidt [Allemagne] ; C. Fiehn [Allemagne] ; A. Jacobi [Allemagne] ; C. Iking-Konert [Allemagne] ; C. Kneitz [Allemagne] ; R E Schmidt [Allemagne] ; B. Bannert [Allemagne] ; R E Voll [Allemagne] ; R. Fischer-Betz [Allemagne] ; I. Kötter [Allemagne] ; H P Tony [Allemagne] ; J. Holle [Allemagne] ; M. Aringer [Allemagne] ; A. Erler [Allemagne] ; F. Behrens [Allemagne] ; G R Burmester [Allemagne] ; T. Dörner [Allemagne]	[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].
001323 (2018)	Abdul Rafeh Naqash [États-Unis] ; Li V. Yang [États-Unis] ; Edward J. Sanderlin [États-Unis] ; Druid C. Atwell [États-Unis] ; Paul R. Walker [États-Unis]	Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report.
001326 (2018)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]	Interleukin (IL-6) Immunotherapy.
001612 (2017)	Tawfik Khoury [Israël] ; Vered Molho-Pessach [Israël] ; Yuval Ramot [Israël] ; Abu Rmeileh Ayman [Israël] ; Orly Elpeleg [Israël] ; Neville Berkman [Israël] ; Abraham Zlotogorski [Israël] ; Yaron Ilan [Israël]	Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome.
001643 (2017)	Marina Mesquida [Espagne] ; Blanca Molins [Espagne] ; Víctor Llorenç [Espagne] ; Maite Sáinz De La Maza [Espagne] ; Alfredo Adán [Espagne]	Targeting interleukin-6 in autoimmune uveitis.
001886 (2017)	Gianluca Moroncini [Italie] ; Giovanni Calogera [Italie] ; Devis Benfaremo [Italie] ; Armando Gabrielli [Italie]	Biologics in Inflammatory Immune-mediated Systemic Diseases.
001940 (2016)	M. Jachiet [France] ; M. Rybojad [France] ; J-D Bouaziz [France]	[What's new in internal medecine?]
001941 (2016)	Jaume Alijotas-Reig [Espagne] ; Enrique Esteve-Valverde [Espagne] ; Raquel Ferrer-Oliveras [Espagne]	[Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].
001B12 (2016)	Takeshi Zoshima [Japon] ; Kazunori Yamada ; Satoshi Hara ; Ichiro Mizushima ; Masakazu Yamagishi ; Kenichi Harada ; Yasuharu Sato ; Mitsuhiro Kawano	Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.
001E00 (2016)	Sulaiman M. Al-Mayouf [Arabie saoudite] ; Abdullatif Alenazi [Arabie saoudite] ; Hind Aljasser [Arabie saoudite]	Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety
002051 (2015)	Adrian Bot [États-Unis]	Editorial: in this issue.
002102 (2015)	Ling-Jun Ho [République populaire de Chine] ; Shue-Fen Luo [République populaire de Chine] ; Jenn-Haung Lai [République populaire de Chine]	Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers.
002279 (2014)	F. Pasquet [France] ; M. Pavic [France] ; J. Ninet [France] ; A. Hot [France]	[Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
002325 (2014)	Xin Yao [États-Unis] ; Jiaqi Huang [États-Unis] ; Haihong Zhong [États-Unis] ; Nan Shen [République populaire de Chine] ; Raffaella Faggioni [États-Unis] ; Michael Fung [États-Unis] ; Yihong Yao [États-Unis]	Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
002388 (2014)	Yuko Yamaguchi [Japon] ; Koji Furukawa ; Toru Yamamoto ; Yukitoshi Takahashi ; Keiko Tanaka ; Makio Takahashi	Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy.
002410 (2014)	M. Mesquida [Espagne] ; A. Leszczynska ; V. Llorenç ; A. Adán	Interleukin-6 blockade in ocular inflammatory diseases.
002522 (2014)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon]	A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
002812 (2013)	Ziv Rosman [Israël] ; Yehuda Shoenfeld ; Gisele Zandman-Goddard	Biologic therapy for autoimmune diseases: an update.
003430 (2012)	Lisa Kaly [Israël] ; Itzhak Rosner	Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases.
003431 (2012)	Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto	Therapeutic targeting of the interleukin-6 receptor.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Autoimmune Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Autoimmune Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Autoimmune Diseases
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021